
Prothena Corporation PLC
NASDAQ:PRTA

Intrinsic Value
The intrinsic value of one
PRTA
stock under the Base Case scenario is
41.16
USD.
Compared to the current market price of 7.35 USD,
Prothena Corporation PLC
is
Undervalued by 82%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Prothena Corporation PLC
Fundamental Analysis


Revenue & Expenses Breakdown
Prothena Corporation PLC
Balance Sheet Decomposition
Prothena Corporation PLC
Current Assets | 485.4m |
Cash & Short-Term Investments | 471.4m |
Other Current Assets | 14m |
Non-Current Assets | 61.7m |
PP&E | 13.8m |
Other Non-Current Assets | 47.9m |
Free Cash Flow Analysis
Prothena Corporation PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Prothena Corporation PLC
Revenue
|
135.2m
USD
|
Operating Expenses
|
-289.7m
USD
|
Operating Income
|
-154.6m
USD
|
Other Expenses
|
32.3m
USD
|
Net Income
|
-122.3m
USD
|
PRTA Profitability Score
Profitability Due Diligence
Prothena Corporation PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Score
Prothena Corporation PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
PRTA Solvency Score
Solvency Due Diligence
Prothena Corporation PLC's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Score
Prothena Corporation PLC's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRTA Price Targets Summary
Prothena Corporation PLC
According to Wall Street analysts, the average 1-year price target for
PRTA
is 52.79 USD
with a low forecast of 20.2 USD and a high forecast of 115.5 USD.
Dividends
Current shareholder yield for PRTA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PRTA
stock under the Base Case scenario is
41.16
USD.
Compared to the current market price of 7.35 USD,
Prothena Corporation PLC
is
Undervalued by 82%.